Thermo Fisher Scientific is the world leader in serving science, our mission is to enable our customers to make the world healthier, cleaner and safer. High-content screening/analysis (HCS) was invented by and registered as a trademark of Cellomics, which is now part of Thermo Fisher Scientific. Our high-content screening portfolio consists of Thermo Scientific CellInsight CX5, CX7 LED, and CX7 LZR HCS platforms and HCS Studio software designed to provide you cutting-edge images and data in no time. Explore our high-content screening platforms that are designed to provide exceptional resolution for subcellular detection, automated detection, and phenotyping with intact, fixed, or live cells.